Kazia Therapeutics Newsroom

Kazia Therapeutics | 20-F: FY2024 Annual Report

SECNov 15 16:10 ET · Announcements

Kazia Therapeutics Secures Nasdaq Compliance

TipRanksNov 12 10:40 ET

Express News | Kazia Therapeutics -Got Letter From Nasdaq Informing Co Has Regained Compliance With Minimum Bid Price Requirement for Continued Listing

ReutersNov 12 10:09 ET

Kazia Therapeutics Management to Meet With Maxim

TipRanksNov 10 17:10 ET

Express News | Kazia Therapeutics Ltd - Full Data From Paxalisib Arm Expected Later This Year

ReutersNov 4 07:30 ET

Kazia Therapeutics Announces Granting of Type C Meeting With FDA to Discuss Potential Next Steps for Paxalisib in the Treatment of Newly Diagnosed Glioblastoma Multiforme

PR NewswireNov 4 07:30 ET

Kazia Therapeutics Trading Halted, News Pending

TipRanksOct 25 19:50 ET

Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

BenzingaOct 25 19:50 ET

Kazia Therapeutics To Carry Out 1-for-10 Reverse Stock Split On October 28th, 2024

Moomoo NewsOct 16 19:35 ET

Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women

PR NewswireOct 15 07:32 ET

Kazia Therapeutics Adjusts ADS Ratio to Boost Nasdaq Listing

TipRanksOct 15 07:27 ET

Express News | Kazia Therapeutics- Plans to Change Ratio of Adss to One Ads Representing 100 Ordinary Shares

ReutersOct 15 07:13 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaOct 3 08:06 ET

Kazia Therapeutics Announces Presentation of Promising Phase I Data Evaluating Concurrent Paxalisib and Radiation Therapy in Patients With Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations at the American...

PR NewswireOct 2 08:45 ET

Kazia Therapeutics Announces Presentation of EVT801 Clinical Data at 15th Biennial Ovarian Cancer Research Symposium

PR NewswireSep 23 08:30 ET

Kazia Therapeutics Advances Cancer Treatment Options

TipRanksSep 13 09:27 ET

Kazia Therapeutics Enters Into Licensing Agreement With QIMR Berghofer

Seeking AlphaSep 12 07:40 ET

Express News | Kazia Therapeutics Ltd - Receives Exclusive Worldwide License for Pi3K Inhibitor Combinations

ReutersSep 12 07:30 ET

Express News | Kazia Executes Licensing Agreement With Qimr Berghofer

ReutersSep 12 07:30 ET

KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER

PR NewswireSep 12 07:30 ET